Vitamin A plays an indispensable role in diverse physiological functions including vision, immunity and growth [1]. Vitamin A deficiency (VAD) – serum retinol level < 0.70 µmol/l – is a major health problem affecting more than one-third (equivalent to 190 million) of the global preschool children. About five million preschool children are also affected by night blindness. Based on the extent of the problem, VAD has moderate or severe public health significance in more than 120 countries. Africa and South-East Asia countries take the highest burden of the deficiency [2].
VAD seriously limits the wellbeing and survival of children [1, 2]. The deficiency is the single most important cause of preventable blindness in the developing world and increases risk of child mortality and morbidity secondary to diarrhea and measles [1, 3]. Systematic review of vitamin A supplementation (VAS) trials concluded that vitamin A reduces all-cause child mortality and diarrhea-related mortality by nearly a quarter [3, 4]. It also substantially cuts the incidence of diarrhea, measles and xerophthalmia [3].
In Ethiopia, despite the decline witnessed in the last three decades, child mortality remains high. According to the recent Demographic and Health Survey (DHS) 2016, out of 1,000 live-births, 48 and 67 die before celebrating their first and fifth birthdays, respectively [5]. A national survey conducted in 2007 concluded that 38% of children 6 to 71 months had low serum vitamin A levels and 1.7 had Bitot's spots [6]. Another large-scale study conducted in 238 Community Based Nutrition program implementing districts of the country estimated that VAD caused 80,000 deaths in a year and affected 61% of children under the age of five years [7, 8].
VAS is considered as a quick and cost-effective strategy for improve VA status in settings where VAD is a public health problem [9]. The World Health Organization (WHO) recommends for the routine administration of VAS to children 6–59 months twice a year [9]. VAS coverage of 80% or more is necessary to achieve the child mortality reduction of the intervention [10]. However, the global coverage remains unsatisfactory. A recent estimate based on several DHS surveys indicated that in Sub-Saharan Africa nearly half of pre-school children did not get the supplement [11].
In Ethiopia routine VAS program has been in place for about two decades and the National Nutrition Program (NNP) promotes the distribution of the supplement to children [8]. In the last two decades, the supplementation had been actively implemented at grassroots level via the routine Health Extension Program (HEP) and other campaign-based approaches – Enhanced Outreach Strategy (EOS) and Community Health Day (CHD) modalities. However, the coverage remains unsatisfactory. According to the Ethiopian DHS 2016, 45% of the eligible children received the supplement in the preceding 6 months of the survey [5]. In 2011, the national coverage was even higher (56%) [12]. Since 2010, the delivery of vitamin A supplements in Ethiopia had gradually shifted from campaign-based approach to routine delivery via the HEP [13].
So far limited evidence exists regarding the factors that affect the utilization of VAS in Ethiopia. Accordingly, this study was conducted to assess the coverage of and factors associated with uptake of routine VAS in Humbo district, Southern Ethiopia. Especially, the study was relevant as it was carried out after transition of VAS distribution from campaign-based approach to routine delivery via the HEP was completed in the district.